T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant - Contacts and Locations

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

This study is currently recruiting participants.

Study NCT00651716. Last updated on November 13, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00651716

Locations


United States, Tennessee
	Vanderbilt-Ingram Cancer Center - Cool Springs	Recruiting
	Nashville, Tennessee, United States, 37064
	Contact: Brian Engelhardt 6-0975
	Vanderbilt-Ingram Cancer Center at Franklin	Recruiting
	Nashville, Tennessee, United States, 37064
	Contact: Brian Engelhardt 6-0975
	Vanderbilt-Ingram Cancer Center	Recruiting
	Nashville, Tennessee, United States, 37232-6838
	Contact: Clinical Trials Office - Vanderbilt-Ingram Cancer Center 800-811-8480

Sponsors and Collaborators

Vanderbilt-Ingram Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Brian Engelhardt, MD	Vanderbilt-Ingram Cancer Center